All Articles

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

As a key architect of its global manufacturing retires, Alliance Laundry bets on financial discipline and investor savvy to drive its next growth cycle.

As AI and cyber risks escalate, the new 'Chief Trust Officer' role is emerging. HITRUST's appointment of a veteran leader signals a major shift for all.

Shake Shack's lowered guidance reveals a consumer trading down from premium burgers, a worrying sign for the entire fast-casual industry's health.

A new partnership between Pioneer Energy and Rolfson Oil is slashing costs and emissions by turning wasted wellhead gas into valuable fuel for frac fleets.

Darigold's partnership with Actus Nutrition isn't a retreat, but a strategic masterstroke redefining the value of milk in a high-tech protein market.

A novel probiotic, sourced from an elite athlete's gut, has navigated the FDA's complex regulatory maze, signaling a major shift for the entire industry.

Ahead of its token launch, nGRND has drawn 855k gamers with a novel promise: rewards backed by preserved, unmined gold. Is this the future of Web3?

The 'better-for-you' brand is betting on a booming peanut butter market with its first non-chocolate snack, a strategic move backed by deep market data.

The Dallas Cowboys are using a new device to build muscle. It’s part of a high-stakes trend where technology is redefining athlete recovery and longevity.

With an $18M Series A, Novellia is flipping the script on real-world data, empowering patients to solve a decades-old, multi-billion-dollar R&D bottleneck.

Frazier Healthcare Partners adds Milton Boyer as an EIR, signaling a strategic push into the complex pharmaceutical manufacturing sector with a proven operator.

With a $1.25 billion investment from Apollo Funds, McKesson is spinning off its medical supply unit. Is this a cure for corporate bloat or a new symptom of financialization in healthcare?

Zacks Investment Management launches two new income ETFs, ZINC and PRIZ, targeting an 8% yield. But can their 'simple', research-driven approach deliver?

At InfoComm 2026, Taiwan isn't just selling hardware. It's unveiling a national strategy to dominate the future of AI-driven enterprise technology.

As AI-powered cyberattacks escalate, one company is fighting fire with fire. Skyhawk Security's award-winning AI Red Team is a game-changer.

As Recursion heads to a key investor conference, it must prove its AI-powered drug discovery platform can deliver financial results, not just scientific promise.

Medscape's new AI symposium aims to guide hematologists through an ethical revolution, promising to enhance, not replace, clinical expertise. Is this the future?

Shift Browser's Impact Grant isn't just about money; it's a new blueprint for how the tech industry can fund the very solutions needed to fix its own mess.

A new partnership between SoundExchange and IFPI automates a critical piece of music's data puzzle, promising fairer pay and less bureaucracy for indie artists.